We are live on ! Find out more
MYOK

MyoKardia, Inc. Common Stock
MYOK

Delisted

MYOK was delisted on the 16th of November, 2020.

Back to rankings

63 hedge funds and large institutions have $233M invested in MyoKardia, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 31 increasing their positions, 7 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,800% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 1

343% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 7

89% more capital invested

Capital invested by funds: $123M → $233M (+$110M)

40% more funds holding

Funds holding: 45 → 63 (+18)

Holders
63
Holders Change
+18
Holders Change %
+40%
% of All Funds
1.68%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
19
Increased
31
Reduced
7
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$27M
2
CAM
Cormorant Asset Management
Massachusetts
+$15.3M
3
PHS
PFM Health Sciences
California
+$6.4M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$3.87M
5
DCM
Driehaus Capital Management
Illinois
+$3.76M

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$3.22M
2
CC
Casdin Capital
New York
-$344K
3
TCIM
TIAA CREF Investment Management
New York
-$39.8K
4
UBS Group
UBS Group
Switzerland
-$8K
5
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$4.51K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$63.6M +$2.37M +131,000 +3%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$51.1M +$27M +1,496,995 +92%
CAM
3
Cormorant Asset Management
Massachusetts
$26.2M +$15.3M +847,500 +112%
PHS
4
PFM Health Sciences
California
$19.5M +$6.4M +354,227 +42%
PA
5
Perceptive Advisors
New York
$10.4M +$2.38M +132,000 +26%
Vanguard Group
6
Vanguard Group
Pennsylvania
$8.65M +$3.87M +214,310 +68%
DM
7
Deerfield Management
New York
$8.17M +$2.26M +125,000 +33%
DCM
8
Driehaus Capital Management
Illinois
$6.74M +$3.76M +207,995 +102%
BFA
9
BlackRock Fund Advisors
California
$5.12M +$419K +23,180 +8%
JP Morgan Chase
10
JP Morgan Chase
New York
$2.81M -$3.22M -178,475 -51%
CC
11
Casdin Capital
New York
$2.61M -$344K -19,029 -11%
State Street
12
State Street
Massachusetts
$2.35M +$441K +24,402 +20%
Northern Trust
13
Northern Trust
Illinois
$2.19M +$423K +23,431 +21%
BIT
14
BlackRock Institutional Trust
California
$2.15M +$856K +47,396 +56%
BBA
15
Baker Bros. Advisors
New York
$1.63M +$1.81M +100,000 New
Marshall Wace
16
Marshall Wace
United Kingdom
$1.63M +$1.81M +100,000 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$1.6M +$583K +32,306 +49%
SFM
18
Sphera Funds Management
Israel
$1.36M +$1.5M +83,240 New
Millennium Management
19
Millennium Management
New York
$1.33M +$1.47M +81,556 New
MIM
20
Monashee Investment Management
Massachusetts
$1.06M – – –
DCM
21
Dialectic Capital Management
Connecticut
$984K +$1.09M +60,200 New
USAA
22
United Services Automobile Association
Texas
$917K +$1.01M +56,100 New
MCM
23
Moore Capital Management
New York
$817K +$903K +50,000 New
EI
24
EAM Investors
California
$748K +$827K +45,794 New
BIM
25
BlackRock Investment Management
Delaware
$691K -$1.3K -72 -0.2%
1
2 3

MYOK Hedge Fund Activity: Q3 2016 in Review

63 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q3 2016, worth a combined $233M — up 89% from $123M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new MYOK positions and 1 closed out — a net gain of 18 holders — while 31 added to existing stakes and 7 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $27M. The largest seller was JP Morgan Chase, cutting an estimated $3.22M.

  • 63 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q3 2016, up from 45 in Q2 2016.
  • Funds reported $233M of MyoKardia, Inc. Common Stock stock for Q3 2016, up 89% quarter-over-quarter.
  • 19 funds opened new MyoKardia, Inc. Common Stock positions in Q3 2016 and 1 closed out, a net change of +18 holders.
  • The largest MyoKardia, Inc. Common Stock buyer in Q3 2016 was Wellington Management Group, an estimated $27M added.
  • The largest MyoKardia, Inc. Common Stock seller in Q3 2016 was JP Morgan Chase, an estimated $3.22M sold.

Based on aggregated 13F filings for Q3 2016.